Abstract
Current guidelines recommend that patients receive warfarin for 3-4 weeks before and after cardioversion of atrial fibrillation (AF). Anticoagulation guided by transesophageal echocardiography (TEE) has been shown to be a viable alternative for cardioversion in AF patients with short-term or no anticoagulation. But how useful is the TEE-guided approach in AF patients who are receiving effective anticoagulation (INR, 2-3) …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
